Search Results

The 18th National Symposium on Radiopharmaceuticals and Labeled Compounds Held in Chongqing, Focusing on Alpha Nuclide Targeting and Theranostics

The 18th National Symposium on Radiopharmaceuticals and Labeled Compounds was held on October 10-11 at the Chongqing Science Hall. The conference was co-hosted by the China Isotope & Radiation Corporation Research Institute and the IAEA Collaborating Centre for Radiopharmaceuticals and Radioactive Sources, co-organized by the Nuclear Medicine Branch of the Chinese Medical Association, the Isotope Branch of the Chinese Nuclear Society, the Radiopharmaceuticals Branch of the Chinese Nuclear Society, and the Nuclear Chemistry and Radiochemistry Branch of the Chinese Nuclear Society, and undertaken by China Isotope & Radiation Corporation and the Chongqing Nuclear Society. More than 400 experts, scholars, clinicians and...

2026-10-12

GE HealthCare Plans $945 Million All-Cash Acquisition of Sofie Biosciences: Full-Scale Positioning in the "Final Mile" Delivery of Positron Radiopharmaceuticals and CDMO Capacity

GE HealthCare, the Chicago-based medical imaging and radiodiagnostics giant, has announced that it has entered into a definitive acquisition agreement to acquire radiopharmaceutical company Sofie Biosciences in an all-cash deal valued at $945 million from private equity firm Trilantic North America. The transaction is expected to complete all regulatory approvals and closing procedures by July 2027, and is expected to be accretive to GE HealthCare's revenue growth and adjusted earnings in the first full fiscal year following closing. Founded in 2008 and headquartered in Dulles, Virginia, Sofie Biosciences has built a broad radiopharmaceutical production and distribution network across the United States...

2026-10-08

Armenia and Rosatom Coordinate the Second Life Extension of Metsamor NPP Unit 2: Reviewing Phase Results and Locking In Key Tasks for 2027–2030

On October 7, 2026, the fifth working meeting of the Joint Coordination Committee of the Republic of Armenia and Rosatom was held in Yerevan, comprehensively reviewing the phased implementation results of the major project for the second life extension (LTO-2) of Unit 2 of the Armenian NPP (ANPP, located in Metsamor), and formally countersigned the execution agreement for advancing engineering tasks from 2027 to 2030. Kirill Komarov, First Deputy Director General and Director for International Business Development of Rosatom, led the Russian delegation, while Narek Apitonyan, Deputy Minister of Territorial Administration and Infrastructure of Armenia, led the Armenian delegation.

2026-10-08

Rosatom Proposes New VVER-1000 Nuclear Power Unit to Armenia

Alexey Likhachev, Director General of Rosatom, recently stated in Yerevan that the company has submitted specific proposals to the Armenian government for the construction of a gigawatt-class VVER-1000 nuclear power unit. The proposal is based on an assessment of Armenia's electricity demand through 2040 and plans to adopt Russia's mature pressurized water reactor technology, the VVER-1000, which features Generation 3+ safety systems and competitive electricity pricing advantages, and has already been built and commissioned in Russia, India, Iran, and other countries. The Russian side calls this option the optimal choice for the international market and is willing to develop the project into a comprehensive cooperation project attracting international suppliers. Previously, Likhachev held talks with Armenian Prime Minister Nikol Pashinyan and...

2026-10-03

New Generation "Harmony System" and Other Technological Achievements Debut at the 23rd China-ASEAN Expo

At the five-day 23rd China-ASEAN Expo and China-ASEAN Business and Investment Summit, CGN showcased its innovative achievements in nuclear power, new energy, and digitalization under the theme "Smart Nuclear Powers Free Trade, Green Electricity Connects ASEAN." At the exhibition, CGN Digital Technology highlighted its independently developed Harmony System series products and their applications in the new energy sector, and used virtual reality technology to give visitors the opportunity to tour nuclear power plants. The Harmony System is hailed as the "nerve center" and "brain" of nuclear power plants. It is China's independently developed nuclear safety-class digital instrumentation and control system, and has now been widely applied to 34 nuclear power units nationwide, covering second- to fourth-generation nuclear power reactor types and technologies. Through the comprehensive iterative upgrading of the Harmony System, CGN Digital Technology has equipped it with a smarter, safer, and more economical "super intelligent brain," aiming to provide digital and intelligent empowerment for the full-cycle production and operation of nuclear power plants.

2026-09-22

Armenia and the IAEA discuss the extension of the Metsamor Nuclear Power Plant and the selection of the reactor type for a new nuclear power plant

On September 15, Armenian Minister of Territorial Administration and Infrastructure David Khudatyan and International Atomic Energy Agency (IAEA) Director General Rafael Mariano Grossi held talks in Vienna, during which the two sides held in-depth discussions on the progress of the life extension project for Unit 2 of the Armenian Nuclear Power Plant (ANPP) and the selection of the reactor type for a new nuclear power plant. According to a message posted by Khudatyan on social media, the talks were held during the 70th IAEA General Conference. We discussed with Rafael Grossi the ongoing and planned projects under the framework of industry cooperation with the IAEA...

2026-09-16

U.S. Army Deploys First Commercial Microreactor at Crane Base

The U.S. Army announced that it has ordered the first commercial microreactor for Naval Support Activity Crane in Indiana, marking a significant step in the United States' application of advanced nuclear energy technology. This micro-modular reactor (MMR), owned and operated by a commercial entity, will be installed at the base, becoming the U.S. Navy's first land-based advanced micro-modular reactor and Indiana's first power reactor. Naval Support Activity Crane is positioned by the U.S. Army as one of the leading centers in operational innovation and capability development. The deployment of the microreactor aims to provide reliable, 24-hour uninterrupted power, reducing dependence on the commercial power grid, thereby supporting critical missions in various...

2026-09-16

GE HealthCare Plans $1 Billion Acquisition of Radiopharmaceutical Company Sofie Biosciences

According to reports, healthcare giant GE HealthCare is in talks to acquire radiopharmaceutical company Sofie Biosciences for $1 billion. It is understood that this acquisition will be another major business move for GE HealthCare since its spin-off from General Electric Company in 2023. Previously, the company reached an agreement in March of this year to acquire software company Intelerad for $2.3 billion, aiming to enhance its cloud-based enterprise imaging service capabilities. Sofie Biosciences was founded in 2008 and is headquartered in Dulles, Virginia. The company has a well-established radiopharmaceutical production and distribution network and provides contract manufacturing services. In addition, Sofie Biosci...

2026-09-15

Canada Supports IAEA "Rays of Hope" Initiative for the First Time, Will Provide Medical Isotope Training for Latin America

The Canadian Nuclear Isotope Council (CNIC) announced on September 10 that Canada has for the first time formally provided support to the International Atomic Energy Agency (IAEA) Rays of Hope initiative, and will help enhance cancer diagnosis and treatment capacity in Latin America through training in the production of medical radioisotopes and radiopharmaceuticals. The Rays of Hope initiative aims to expand access to cancer treatment and radiotherapy infrastructure in low- and middle-income countries. Under the arrangement, from November 8 to 14, 26 relevant sector leaders from Argentina, Brazil, Chile and Mexico will travel to Ontario, Canada, to participate in a training program jointly organized by Bruce Power and McMaster University. The training will focus on medical isotopes...

2026-09-11

South Korea's First Animal Radiopharmaceutical Approved for the Treatment of Feline Hyperthyroidism

The Korea Atomic Energy Research Institute announced on September 10 that Thyrokitty Injection (I-131), a radiopharmaceutical for the treatment of feline hyperthyroidism developed by the research team led by Dr. Lim Jae-cheong, has obtained an animal drug manufacturing license issued by the Animal and Plant Quarantine Agency of South Korea. This is South Korea's first animal radiopharmaceutical to receive final product approval, marking the transition of related technologies that had previously been mainly at the R&D stage into clinical therapeutic application for pets. Feline hyperthyroidism is a relatively common endocrine disease in older cats, mainly characterized by excessive secretion of thyroid hormones. According to reports, approximately 10% of cats aged 10 and above may suffer from this disease. Traditional treatment methods typically require...

2026-09-10

ITM and SpiroChem Announce Strategic Collaboration to Advance Novel Radiopharmaceutical Development

Garching/Munich, Germany and Basel, Switzerland, September 8, 2026 – Radiopharmaceutical biotechnology company ITM Isotope Technologies Munich SE and Swiss collaborative research organization SpiroChem AG today announced a strategic drug discovery partnership focused on a novel radiopharmaceutical candidate within ITM's pipeline. The specific target and financial terms of the collaboration were not disclosed. Under the agreement, the parties will combine their respective capabilities to advance candidate discovery and optimization. SpiroChem will leverage its drug discovery platform, macrocycle library, and screening engine to lead hit identification and optimization, while ITM will provide...

2026-09-09

BESIII Experiment Achieves High-Precision Measurement of Charm Meson Semileptonic Decays and First Constraint on "Scalar Current"

Recently, the BESIII international collaboration utilized the world's largest near-threshold charm meson data sample to perform a combined measurement of four semileptonic decay channels: D⁰→K⁻e⁺νₑ, D⁰→K⁻μ⁺νμ, D⁺→K̄⁰e⁺νₑ, and D⁺→K̄⁰μ⁺νμ. The research team extracted the quark mixing matrix element |Vcs| with a precision better than 0.5%, determined the form factor zero-point value f₊(0) with a precision better than 0.2%, and verified lepton universality in the above processes at the 0.5% precision level. Beyond these precise determinations of Standard Model parameters, what is particularly noteworthy is that this experiment has, for the first time...

2026-09-08

Armenian NPP Unit 2 Reconnected to Grid After Overhaul

September 3 news, Armenian Minister of Territorial Administration and Infrastructure David Khudatyan stated that Unit 2 of the Armenian Nuclear Power Plant has resumed operation and been connected to the country's unified power grid after completing a five-month planned overhaul. Khudatyan said that on September 1, 2026, Unit 2 of the Armenian Nuclear Power Plant was restarted after scheduled maintenance and connected to the national unified power grid. Currently, the unit is operating normally, with power output gradually increasing in accordance with established process requirements. The planned overhaul began on April 1 and lasted 153 days as scheduled. During the overhaul, approximately 20 measures were implemented at the plant to enhance unit reliability, safety, and operational efficiency...

2026-09-08

South Korea's DuChemBio to Build Country's First Radiopharmaceutical CDMO Plant

South Korean radiopharmaceutical therapy company DuChemBio will build the country's first contract development and manufacturing organization (CDMO) plant dedicated to radiopharmaceuticals, in response to growing demand for radiopharmaceuticals used in the diagnosis and treatment of cancer and neurological diseases. DuChemBio is a subsidiary of healthcare distributor Geo-Young Group. The company recently signed an investment agreement with North Jeolla Province and the city of Jeongeup to invest KRW 34.3 billion (approximately USD 25.5 million) in building a new plant in Jeongeup. The company stated that this is the largest investment since Geo-Young acquired DuChemBio. According to the plan, the new facility will integrate radioisotope production...

2026-09-08

Atom High-Tech Signs Memorandum of Cooperation with Cambodia's Calmette Hospital and Others to Advance Nuclear Medicine Capacity Building

On September 4, Atom High-Tech, Cambodia's Calmette Hospital, and FFS Company held a trilateral memorandum of cooperation signing ceremony in Beijing. Huo Yingying, Deputy Secretary of the Party Committee of China Isotope & Radiation Corporation (CIRC), attended and delivered a speech, while Zhang Yiming, Secretary of the Party Committee and Chairman of Atom High-Tech, signed on behalf of the company. Established in 1950, Calmette Hospital is one of Cambodia's largest and most technologically advanced public hospitals and serves as a national referral center. It undertakes three core missions: delivering high-quality medical services, training health professionals, and conducting medical research. Currently, the hospital is actively advancing its nuclear medicine capacity by establishing the country's first nuclear medicine department, further improving its oncology diagnosis and treatment and molecular imaging service systems...

2026-09-07